Narrativa Raises An Additional $1.3M To Help Pharma Companies Accelerate The Fda Drug Approval Process Through Artificial Intelligence Natural Language Generation

May 18, 2021•over 4 years ago

Amount Raised

$1.3 Million

Round Type

seed

Los Angeles

Description

Narrativa, which has built an artificial intelligence (AI) medical writing platform to help pharmaceutical companies accelerate the drug approval process and lower the overall cost of compliance, recently closed its $1.3 million financing round.

Company Information

Company

Narrativa

Location

Los Angeles, California, United States

About

Founded in 2015, Narrativa was created from the belief that technology can be used to transform the world in a positive way. Recognized by Samsung as one of the most important companies in the NLG field, Narrativa supports businesses that want to grow by anticipating trends and transforming data into human language in real time. Through its artificial intelligence system and experience in machine learning, Narrativa produces automated content in diverse fields, including finance, pharmaceuticals, insurance, media, and gaming among others. Visit www.Narrativa.com to learn more. Contact:Matthew RectorNarrativa, USA[email protected] Direct: (323) 487-2901 Sofia SanchezNarrativa, International[email protected] SOURCE Narrativa

Narrativa Raises An Additional $1.3M To Help Pharma Companies Accelerate The Fda Drug Approval Process Through Artificial Intelligence Natural Language Generation

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information